Product Code: GVR-4-68040-008-6
PMS And Menstrual Health Supplements Market Growth & Trends:
The global PMS and menstrual health supplements market size is expected to reach USD 35.0 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.7% from 2023 to 2030. One of the major factors contributing to the growth of the market is increased awareness among women about the health hazards related to menstrual health. Traditional diets these days are not able to meet daily nutrient requirements, hence, many physicians are recommending women add health supplements to their daily routine, thus increasing the market growth. The emergence of the COVID-19 pandemic led to increasing awareness about physical and mental health. Additionally, trending e-commerce has eased access to health supplements. Furthermore, industry players globally are focusing on the R&D of new nutritional products to meet market demand.
A study published in the General Psychiatry Journal suggests that 90% of women will experience mild to severe premenstrual syndrome in 2020. To help patients handle premenstrual syndrome, leading manufacturers in the field of PMS treatments are focusing on the consumption of vitamin and nutritional supplements. Years of studies show several vitamins and minerals, including vitamin B, vitamin C, magnesium, and calcium, are vital nutrients in treating PMS-related symptoms. Among all these nutrients, Vitamin B is the most essential and helps to lower PMS.
In 2022, Asia Pacific held a dominant revenue share. Demand for these supplements in the Asia Pacific region will be fuelled by the increasing number of PMS cases, thus giving rise to the general wellness trend. China held the largest share in the Asia Pacific market in 2022, followed by India and Japan. The Middle East and Africa is estimated to witness the fastest growth during the forecast period. Iran shows a high rate of PMS prevalence in the MEA. Numerous lucrative business opportunities are expected to arise as a result of the rising popularity of healthy lifestyles.
PMS And Menstrual Health Supplements Market Report Highlights:
- The market is expected to grow due to increasing awareness regarding menstrual syndrome and adopting a healthy lifestyle
- Based on product, combined nutritional supplements dominated the market in 2022. These products offer reliability, which makes them the first choice of recommendation by physicians
- By consumer group, PMS held the largest share in 2022. This can be attributed to the rise in its prevalence globally. Other factors contributing to this growth include the effectiveness of nutritional supplements in controlling this condition
- Consumers' awareness regarding their nutritional needs has increased significantly as a result of the COVID-19 pandemic, and hence, they are beginning to recognize the value of nutritional supplements. As a result, it promotes sales growth
- The MEA is expected to grow at the fastest rate during the forecast period. The rise in the prevalence rate contributes to the regional market growth
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definition
- 1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.1.1. Purchased database
- 1.3.1.2. GVR's internal database
- 1.3.2. Primary Research
- 1.4. Research Scope and Assumptions
- 1.5. List to Data Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
- 2.4. PMS and Menstrual Health Supplements Market
Chapter 3. PMS and Menstrual Supplements Market Variables, Trends, & Scope
- 3.1. Penetration and Growth Prospect Mapping
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. PMS and Menstrual Supplements Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.3. Major Deals & Strategic Alliances Analysis
Chapter 4. PMS and Menstrual Supplements Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.2. PMS and Menstrual Supplements Market: Product Analysis, 2022 & 2030 (USD Billion)
- 4.2.1. Single Nutritional Supplements
- 4.2.1.1. Vitamins
- 4.2.1.1.1. Vitamins market estimates and forecasts, 2017 - 2030 (USD Billion)
- 4.2.1.2. Minerals
- 4.2.1.2.1. Minerals market estimates and forecasts, 2017 - 2030 (USD Billion)
- 4.2.1.3. Herbal Supplements
- 4.2.1.3.1. Herbal Supplements market estimates and forecasts, 2017 - 2030 (USD Billion)
- 4.2.1.4. Others
- 4.2.1.4.1. Others market estimates and forecasts, 2017 - 2030 (USD Billion)
- 4.2.2. Combined Nutritional Supplements: Product Analysis, 2022 & 2030 (USD Billion)
Chapter 5. PMS and Menstrual Supplements Market: Consumer Group Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.2. PMS and Menstrual Supplements Market: Consumer Group Analysis, 2022 & 2030 (USD Billion)
- 5.2.1. Premenstrual Syndrome (PMS)
- 5.2.1.1. Premenstrual Syndrome (PMS) estimates and forecasts, 2017 - 2030 (USD Billion)
- 5.2.2. Perimenopause
- 5.2.2.1. Perimenopause Syndrome estimates and forecasts, 2017 - 2030 (USD Billion)
Chapter 6. PMS and Menstrual Supplements Market: Formulation Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.2. PMS and Menstrual Supplements Market: Formulation Analysis, 2022 & 2030 (USD Billion)
- 6.2.1. Capsules/Tablets
- 6.2.1.1. Capsule/Tablets estimates and forecasts, 2017 - 2030 (USD Billion)
- 6.2.2. Powder
- 6.2.2.1. Powder estimates and forecasts, 2017 - 2030 (USD Billion)
- 6.2.3. Softgels
- 6.2.3.1. Softgels estimates and forecasts, 2017 - 2030 (USD Billion)
- 6.2.4. Others
- 6.2.4.1. Others estimates and forecasts, 2017 - 2030 (USD Billion)
Chapter 7. PMS and Menstrual Supplements Market: Sales channel Estimates & Trend Analysis
- 7.1. Definitions and Scope
- 7.2. PMS and Menstrual Supplements Market: Sales channel Analysis, 2022 & 2030 (USD Billion)
- 7.2.1. Online sales channel
- 7.2.1.1. Online sales channel estimates and forecasts, 2017 - 2030 (USD Billion)
- 7.2.2. Direct sales channel
- 7.2.2.1. Direct sales channel estimates and forecasts, 2017 - 2030 (USD Billion)
- 7.2.3. Pharmacies/Drug store
- 7.2.3.1. Pharmacies/Drug store estimates and forecasts, 2017 - 2030 (USD Billion)
- 7.2.4. Other offline channels
- 7.2.4.1. Other offline estimates and forecasts, 2017 - 2030 (USD Billion)
Chapter 8. PMS and Menstrual Supplements Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Snapshot
- 8.2. PMS and Menstrual Supplements Market: Regional Movement Analysis
- 8.3. North America
- 8.3.1. North America market estimates and forecasts, by product,2017 - 2030 (USD Billion)
- 8.3.2. North America market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.3.3. North America market estimates and forecasts, by formulation,2017 - 2030 (USD Billion)
- 8.3.4. North America market estimates and forecasts, by sales channel,2017 - 2030 (USD Billion)
- 8.3.5. U.S.
- 8.3.5.1. U.S. market estimates and forecasts, by product,2017 - 2030 (USD Billion)
- 8.3.5.2. U.S. market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.3.5.3. U.S. market estimates and forecasts, by formulation,2017 - 2030 (USD Billion)
- 8.3.5.4. U.S. market estimates and forecasts, by sales,2017 - 2030 (USD Billion)
- 8.3.6. Canada
- 8.3.6.1. Canada market estimates and forecasts, by product,2017 - 2030 (USD Billion)
- 8.3.6.2. Canada market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.3.6.3. Canada market estimates and forecasts, by formulation,2017 - 2030 (USD Billion)
- 8.3.6.4. Canada market estimates and forecasts, by sales,2017 - 2030 (USD Billion)
- 8.4. Europe
- 8.4.1. Europe market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.2. Europe market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.3. Europe market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.4. Europe market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.4.5. Germany
- 8.4.5.1. Germany market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.5.2. Germany market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.5.3. Germany market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.5.4. Germany market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.4.6. U.K.
- 8.4.6.1. U.K. market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.6.2. U.K. market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.6.3. U.K. market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.6.4. U.K. market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.4.7. France
- 8.4.7.1. France market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.7.2. France market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.7.3. France market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.7.4. France market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.4.8. Italy
- 8.4.8.1. Italy market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.8.2. Italy market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.8.3. Italy market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.8.4. Italy market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.4.9. Spain
- 8.4.9.1. Spain market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.9.2. Spain market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.9.3. Spain market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.9.4. Spain market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.4.10. Denmark
- 8.4.10.1. Denmark market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.10.2. Denmark market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.10.3. Denmark market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.10.4. Denmark market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.4.11. Sweden
- 8.4.11.1. Sweden market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.11.2. Sweden market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.11.3. Sweden market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.11.4. Sweden market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.4.12. Norway
- 8.4.12.1. Norway market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.4.12.2. Norway market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.4.12.3. Norway market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.4.12.4. Norway market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.5. Asia Pacific
- 8.5.1. Asia Pacific market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.5.2. Asia Pacific market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.5.3. Asia Pacific market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.5.4. Asia Pacific market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.5.5. China
- 8.5.5.1. China market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.5.5.2. China Pacific market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.5.5.3. China Pacific market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.5.5.4. China Pacific market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.5.6. Japan
- 8.5.6.1. Japan market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.5.6.2. Japan Pacific market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.5.6.3. Japan Pacific market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.5.6.4. Japan Pacific market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.5.7. India
- 8.5.7.1. India market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.5.7.2. India Pacific market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.5.7.3. India Pacific market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.5.7.4. India Pacific market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.5.8. Australia
- 8.5.8.1. Australia market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.5.8.2. Australia market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.5.8.3. Australia market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.5.8.4. Australia market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.5.9. South Korea
- 8.5.9.1. South Korea market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.5.9.2. South Korea market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.5.9.3. South Korea market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.5.9.4. South Korea market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.6. Latin America
- 8.6.1. Latin America market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.6.2. Latin America market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.6.3. Latin America market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.6.4. Latin America market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.6.5. Brazil
- 8.6.5.1. Brazil market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.6.5.2. Brazil market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.6.5.3. Brazil market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.6.5.4. Brazil market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.6.6. Mexico
- 8.6.6.1. Mexico market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.6.6.2. Mexico market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.6.6.3. Mexico market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.6.6.4. Mexico market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.6.7. Argentina
- 8.6.7.1. Argentina market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.6.7.2. Argentina market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.6.7.3. Argentina market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.6.7.4. Argentina market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.7. MEA
- 8.7.1. MEA market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.7.2. MEA market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.7.3. MEA market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.7.4. MEA market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.7.5. South Africa
- 8.7.5.1. South Africa market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.7.5.2. South Africa market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.7.5.3. South Africa market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.7.5.4. South Africa market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.7.6. Saudi Arabia
- 8.7.6.1. Saudi Arabia market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.7.6.2. Saudi Arabia market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.7.6.3. Saudi Arabia market estimates and forecasts, by formulation, 2017 - 2030 (USD Billion)
- 8.7.6.4. Saudi Arabia market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.7.7. UAE
- 8.7.7.1. UAE market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.7.7.2. UAE market estimates and forecasts, by consumer group, 2017 - 2030 (USD Billion)
- 8.7.7.3. UAE market estimates and forecasts, by formulation 2017 - 2030 (USD Billion)
- 8.7.7.4. UAE market estimates and forecasts, by sales channel, 2017 - 2030 (USD Billion)
- 8.7.8. Kuwait
- 8.7.8.1. Kuwait market estimates and forecasts, by product, 2017 - 2030 (USD Billion)
- 8.7.8.2. Kuwait market estimates and forecasts, by consumer group 2017 - 2030 (USD Billion)
- 8.7.8.3. Kuwait market estimates and forecasts, by formulation 2017 - 2030 (USD Billion)
- 8.7.8.4. Kuwait market estimates and forecasts, by sales channel 2017 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Competition Categorization
- 9.3. Vendor Landscape
- 9.3.1. Company Market Position Analysis
Chapter 10. Company Profiles
- 10.1 Herbalife International of America, Inc.
- 10.1.1 Company overview
- 10.1.2 Financial performance
- 10.1.3 Product benchmarking
- 10.1.4 Strategic initiatives
- 10.2 Pharmavite LLC
- 10.2.1 Company overview
- 10.2.2 Financial performance
- 10.2.3 Product benchmarking
- 10.2.4 Strategic initiatives
- 10.3 Nature's Bounty
- 10.3.1 Company overview
- 10.3.2 Financial performance
- 10.3.3 Product benchmarking
- 10.3.4 Strategic initiatives
- 10.4 Amway
- 10.4.1 Company overview
- 10.4.2 Financial performance
- 10.4.3 Product benchmarking
- 10.4.4 Strategic initiatives
- 10.5 GNC Holdings, Inc.
- 10.5.1 Company overview
- 10.5.2 Financial performance
- 10.5.3 Product benchmarking
- 10.5.4 Strategic initiatives
- 10.6 USANA Health Sciences, Inc.
- 10.6.1 Company overview
- 10.6.2 Financial performance
- 10.6.3 Product benchmarking
- 10.6.4 Strategic initiatives
- 10.7 GlaxoSmithKline Plc
- 10.7.1 Company overview
- 10.7.2 Financial performance
- 10.7.3 Product benchmarking
- 10.7.4 Strategic initiatives
- 10.8 MetPPharmaAG
- 10.8.1 Company overview
- 10.8.2 Financial performance
- 10.8.3 Product benchmarking
- 10.9 RBK Nutraceuticals Pty Ltd.
- 10.9.1 Company overview
- 10.9.2 Financial performance
- 10.9.3 Product benchmarking
- 10.10 Archer Daniels Midland
- 10.10.1 Company overview
- 10.10.2 Financial performance
- 10.10.3 Product benchmarking
- 10.10.4 Strategic initiatives
- 10.11 Power Gummies
- 10.11.1 Company overview
- 10.11.2 Financial performance
- 10.11.3 Product benchmarking
- 10.11.4 Strategic initiatives
- 10.12 Looni
- 10.12.1 Company overview
- 10.12.2 Financial performance
- 10.12.3 Product benchmarking
- 10.12.4 Strategic initiatives
- 10.13 DM Pharma
- 10.13.1 Company overview
- 10.13.2 Financial performance
- 10.13.3 Product benchmarking
- 10.13.4 Strategic initiatives